Nu Skin Enterprises (NYSE:NUS) Issues FY 2026 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 0.800-1.200 for the period, compared to the consensus EPS estimate of 1.420. The company issued revenue guidance of $1.4 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion. Nu Skin Enterprises also updated its Q1 2026 guidance to 0.100-0.200 EPS.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on NUS shares. Wall Street Zen downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Saturday. Weiss Ratings reiterated a “hold (c)” rating on shares of Nu Skin Enterprises in a research report on Thursday, January 22nd. Finally, Zacks Research raised shares of Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a research note on Friday, January 30th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, Nu Skin Enterprises has a consensus rating of “Hold”.

Nu Skin Enterprises Stock Down 18.0%

Shares of NYSE NUS opened at $8.37 on Friday. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.15 and a quick ratio of 1.45. The stock has a market capitalization of $408.09 million, a P/E ratio of 2.62 and a beta of 1.01. Nu Skin Enterprises has a one year low of $5.32 and a one year high of $14.62. The firm’s 50 day simple moving average is $10.34 and its two-hundred day simple moving average is $10.65.

Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Thursday, February 12th. The company reported $0.29 earnings per share for the quarter, missing the consensus estimate of $0.30 by ($0.01). Nu Skin Enterprises had a net margin of 10.79% and a return on equity of 8.21%. The company had revenue of $370.32 million for the quarter, compared to analysts’ expectations of $382.70 million. Nu Skin Enterprises has set its FY 2026 guidance at 0.800-1.200 EPS and its Q1 2026 guidance at 0.100-0.200 EPS. As a group, analysts expect that Nu Skin Enterprises will post 1.05 EPS for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 11th. Investors of record on Friday, February 27th will be issued a $0.06 dividend. This represents a $0.24 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend is Friday, February 27th. Nu Skin Enterprises’s dividend payout ratio is currently 7.50%.

Key Stories Impacting Nu Skin Enterprises

Here are the key news stories impacting Nu Skin Enterprises this week:

• Positive Sentiment: Board declared a quarterly cash dividend of $0.06 per share (yield ~2.3%), payable Mar. 11 to holders of record Feb. 27 — supports income investors and signals capital-return discipline. Dividend Announcement
• Positive Sentiment: Management is pushing a strategic transformation (including India expansion) and commercial rollout of the Prysm iO device, targeting placement of 100,000 units in 2026 — a potential long-term revenue driver if adoption accelerates. Prysm iO / Strategy Article
• Neutral Sentiment: Company states Q4 and full-year results were within its guidance framework and highlighted >50% growth in 2025 earnings (adjusted), but the positive messaging contrasts with misses vs. external consensus — investors should weigh management framing against external estimates. Business Wire Release
• Neutral Sentiment: Coverage update from Stonegate reiterates reported Q4 numbers (revenue $370.3M; adjusted NI $14.5M; adj EPS $0.29) — a restatement of results rather than a new catalyst. Stonegate Coverage Update
• Negative Sentiment: Q4 results missed consensus: EPS $0.29 vs. $0.30 expected; revenue $370.3M vs. $382.7M expected — revenues fell 16.9% year-over-year with broad declines across key regions, which pressures near-term top-line recovery. Zacks Earnings Miss
• Negative Sentiment: Management cut Q1 and FY2026 guidance meaningfully below consensus — Q1 EPS $0.10–0.20 (street ~$0.29) and FY EPS $0.80–1.20 (street ~$1.42); revenue ranges likewise sit below expectations — the guidance shortfall is the primary driver of the market reaction. Guidance & Press Release
• Negative Sentiment: Analyst and media transcripts reiterate the miss and highlight deteriorating customer counts (paid affiliates down ~10%) and margin pressures; near-term fundamentals appear weaker than the market had modeled. Earnings Call Transcript

Institutional Trading of Nu Skin Enterprises

A number of hedge funds and other institutional investors have recently modified their holdings of NUS. First Trust Advisors LP increased its position in shares of Nu Skin Enterprises by 34.8% during the 4th quarter. First Trust Advisors LP now owns 89,128 shares of the company’s stock valued at $857,000 after purchasing an additional 22,990 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in Nu Skin Enterprises by 22.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,621,785 shares of the company’s stock valued at $25,222,000 after acquiring an additional 481,231 shares during the last quarter. Wells Fargo & Company MN increased its position in Nu Skin Enterprises by 42.9% during the fourth quarter. Wells Fargo & Company MN now owns 56,406 shares of the company’s stock valued at $543,000 after acquiring an additional 16,920 shares during the last quarter. State Board of Administration of Florida Retirement System raised its stake in shares of Nu Skin Enterprises by 90.1% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 155,952 shares of the company’s stock valued at $1,500,000 after acquiring an additional 73,906 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Nu Skin Enterprises by 16.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,373,372 shares of the company’s stock worth $13,212,000 after acquiring an additional 193,987 shares during the last quarter. 82.84% of the stock is owned by hedge funds and other institutional investors.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.